Gary L. Crocker - 14 Feb 2022 Form 4 Insider Report for MERRIMACK PHARMACEUTICALS INC

Role
Chairman, President, and Treasurer, Director
Signature
/s/ Gary L. Crocker
Issuer symbol
N/A
Transactions as of
14 Feb 2022
Net transactions value
+$11,486
Form type
4
Filing time
16 Feb 2022, 15:05:24 UTC
Previous filing
31 Jan 2022
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MACK Common Stock Purchase $10,724 +1,800 +2.5% $5.96 73,409 14 Feb 2022 See footnote F1, F2
transaction MACK Common Stock Purchase $763 +123 +0.17% $6.20 73,532 15 Feb 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.86 to $6.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member.

Remarks:

Chairman, President, and Treasurer